2021
DOI: 10.1038/s41431-021-00887-w
|View full text |Cite
|
Sign up to set email alerts
|

Consolidating biallelic SDHD variants as a cause of mitochondrial complex II deficiency

Abstract: Isolated mitochondrial complex II deficiency is a rare cause of mitochondrial respiratory chain disease. To date biallelic variants in three genes encoding mitochondrial complex II molecular components have been unequivocally associated with mitochondrial disease (SDHA/SDHB/SDHAF1). Additionally, variants in one further complex II component (SDHD) have been identified as a candidate cause of isolated mitochondrial complex II deficiency in just two unrelated affected individuals with clinical features consisten… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
(27 reference statements)
0
1
0
Order By: Relevance
“…Except for LS, multiple point mutations in SDHB are reported in patients with leukoencephalopathy (Alston et al, 2012 ; Ardissone et al, 2015 ; Helman et al, 2016 ; Kaur et al, 2020 ). In patients with early progressive encephalomyopathy, a homozygous or compound heterozygous mutations in SDHD p.E69K and p.*164Lext*3 (a mutation that extends the SDHD C-terminus by the three extra amino acids Leu, Pro, and Phe) was identified (Jackson et al, 2014 ; Lin et al, 2021 ). Moreover, although CI and CIII are the main sources of mitochondrial ROS, growing studies indeed reveal that CII also serves as a source and modulator of ROS (Yankovskaya et al, 2003 ; Hadrava Vanova et al, 2020 ).…”
Section: Dysregulation Of Mitochondrial Bioenergeticsmentioning
confidence: 99%
“…Except for LS, multiple point mutations in SDHB are reported in patients with leukoencephalopathy (Alston et al, 2012 ; Ardissone et al, 2015 ; Helman et al, 2016 ; Kaur et al, 2020 ). In patients with early progressive encephalomyopathy, a homozygous or compound heterozygous mutations in SDHD p.E69K and p.*164Lext*3 (a mutation that extends the SDHD C-terminus by the three extra amino acids Leu, Pro, and Phe) was identified (Jackson et al, 2014 ; Lin et al, 2021 ). Moreover, although CI and CIII are the main sources of mitochondrial ROS, growing studies indeed reveal that CII also serves as a source and modulator of ROS (Yankovskaya et al, 2003 ; Hadrava Vanova et al, 2020 ).…”
Section: Dysregulation Of Mitochondrial Bioenergeticsmentioning
confidence: 99%